Keyphrases
Lung Cancer Patients
100%
EGFR mutation
100%
Exon 21
100%
Exon 19
100%
Plasma Biomarkers
100%
Lung Cancer
37%
Potential Biomarkers
25%
Non-small Cell Lung Cancer (NSCLC)
25%
High-resolution Metabolomics
25%
Epidermal Growth Factor Receptor
12%
South Korea
12%
Linoleic Acid
12%
Early Detection
12%
Univariate Analysis
12%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
12%
Metabolic Profiling
12%
Early Diagnosis
12%
Non-small Cell Lung Cancer Patients
12%
Four-potential
12%
Diagnostic Tool
12%
Hierarchical Cluster Analysis
12%
False Discovery Rate
12%
Path Analysis
12%
Minimally Invasive
12%
L-glutamine
12%
L-carnitine
12%
Metabolic Difference
12%
Mutation Detection
12%
5-methyltetrahydrofolate
12%
Human Plasma Samples
12%
Patient's Will
12%
Most Common Form
12%
Metabolic Alterations
12%
Novel Diagnostics
12%
Semialdehyde
12%
Treatment Type
12%
Metabolome-wide Association Study
12%
Metabolic Network Model
12%
Significant Compounds
12%
Mummichog
12%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Exon
100%
Blood Plasma
100%
Metabolite
22%
Metabolomics
22%
Liquid Chromatography-Mass Spectrometry
11%
Metabolic Network
11%
Metabolome
11%
Fundulus heteroclitus
11%
Glutamic Acid
11%
Linoleic Acid
11%
Tetrahydrofolic Acid
11%